Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

June 28, 2024

https://www.globenewswire.com/news-release/2024/06/28/2905834/0/en/Dyadic-International-Inc-and-Proliant-Health-and-Biologicals-announce-Recombinant-Albumin-Development-and-Commercialization-Partnership.html

JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”) (NASDAQ:DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for the diagnostic, nutrition and cell culture markets.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.